Dr. Ian A. Maher, MD

Dr. Maher practices at Fairview Clinics Specialty in Saint Paul, Minnesota.

Dr. Maher's NPI, 1598925513, was assigned on June 12, 2008. Dr. Maher graduated from JC Edwards School of Medicine, Marshall University in 2005. Dr. Maher holds Minnesota license 63602.

Dr. Maher's primary practice is Fairview Clinics Specialty, at 1700 University W Ave, Saint Paul, MN 55104 in Ramsey County. The practice phone is (612) 672-6740.

Dr. Maher's primary practice is Fairview Clinics Specialty in Saint Paul, Minnesota. Dr. Maher is also affiliated with M Health Fairview University of Minnesota Medical Center. The medical group on file is M Health Fairview Recovery Clinic. Dmand AI also links Dr. Maher to 2 more group practices and clinics, 2 medical groups and 1 ambulatory surgery center, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Maher practices, 4 sites in all. Vendor and product names are available with a free account.

Mohs-micrographic surgery is Dr. Maher's primary specialty in the NPI Registry, under taxonomy code 207ND0101X. Dmand AI has Dr. Maher's licenses on file in 2 states: Minnesota and Missouri.

CMS data shows 1,052 Medicare services from Dr. Maher across 26 procedure codes in 2024, for 310 Medicare patients. Medicare paid $244,556 for them. Every service was in an office.

CMS counts 310 Medicare patients who saw Dr. Maher in 2024. The largest group is 65 to 74, with 139 patients. 71% of them have high blood pressure, and 66% have high cholesterol. 10% are also on Medicaid. Their average risk score is 2.07, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Maher's median patient age at 70, with 50% women.

In 2024, Dr. Maher wrote 138 Medicare Part D claims for 72 patients. 91% of them were for generic drugs. CMS names the drug for 46 of them, across 3 drugs with 11 or more claims each, at $796 in total drug cost. In 2023, CMS named 27 claims across 2 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 93 out of 100 for Dr. Maher for performance year 2024, reported as part of a group. Dr. Maher accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Maher as offering telehealth. CMS counts 161 procedures of melanoma (skin cancer) excision by Dr. Maher, more than 96% of the clinicians it reports for that procedure.

Dmand AI links 111 papers to Dr. Maher, published from 2012 to 2025. 2022 was the busiest year, with 14. The most frequent topics are Skin Neoplasms, Mohs Surgery and Surgical Flaps. Dr. Maher has published most often in Dermatol Surg. Dr. Maher's most frequent co-authors are Joseph F. Sobanko, Todd Vincent Cartee, MD and Adam Reed Mattox, DO.

Dmand AI links Dr. Maher to 2 clinical trials. Conditions studied include Basal Cell Nevus Syndrome, Carcinoma, Basal Cell and Jaw Cysts.

CMS Open Payments shows 16 general payments to Dr. Maher from 4 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 91% of the total. Sun Pharmaceutical Industries Inc. paid the most, $12,588.

Dr. Maher graduated from JC Edwards School of Medicine, Marshall University in 2005.